How CME’s 24/7 Crypto Derivatives Push and New Altcoin Futures At CME Group (CME) Has Changed Its Investment Story

• CME Group has recently expanded its regulated cryptocurrency futures suite to include Cardano, Chainlink, and Stellar, and announced plans for 24/7 crypto futures and options trading access starting May 29, pending regulatory approval.
• This push deeper into digital asset derivatives signals CME’s intent to become a core venue for institutional and retail crypto risk management under regulatory oversight.
• We’ll now examine how CME’s move to 24/7 crypto derivatives trading could reshape its investment narrative and future growth drivers.

Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

CME Group Investment Narrative Recap

To own CME Group, you have to believe that global demand for regulated derivatives and clearing will remain central to how investors manage risk, across both traditional and digital assets. The shift to 24/7 crypto futures and options trading could reinforce CME’s role here in the near term, but it does not fundamentally change the biggest current risk: competition from alternative low fee and decentralized trading venues that could gradually pressure volumes and pricing.

The most closely linked development is CME’s recent expansion of regulated crypto futures to Cardano, Chainlink, and Stellar, lifting coverage to over 75% of total crypto market cap. Together with round the clock access, this broadens CME’s ability to capture crypto hedging and trading flows as a potential volume catalyst, while also testing how far traditional exchange infrastructure can extend into areas where decentralized finance is evolving quickly.

Yet for all this positive momentum, investors should also be aware that…

Read the full narrative on CME Group (it’s free!)

CME Group’s narrative projects $7.3 billion revenue and $4.3 billion earnings by 2028. This requires 4.4% yearly revenue growth and about a $0.6 billion earnings increase from $3.7 billion today.

Uncover how CME Group’s forecasts yield a $299.29 fair value, a 8% downside to its current price.

Exploring Other Perspectives

Four members of the Simply Wall St Community currently estimate CME’s fair value between US$241.99 and US$299.29, reflecting a wide spread of expectations. Against that backdrop, CME’s push into 24/7 crypto derivatives and broader digital asset coverage could be an important offset to the long term competitive threat from decentralized finance, so it is worth comparing several of these viewpoints before deciding how you see the company’s future.

Explore 4 other fair value estimates on CME Group – why the stock might be worth as much as $299.29!

The Verdict Is Yours

Don’t just follow the ticker – dig into the data and build a conviction that’s truly your own.

Contemplating Other Strategies?

Opportunities like this don’t last. These are today’s most promising picks. Check them out now:

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com